• Healthcare agency Page & Page and Partners welcomes wave of new talent

    Nov 19, 2020, 14:56 PM by
    Page & Page and Partners, the global creative communications agency specialising in health, wellness and lifestyle, is today announcing the appointment of three new staff members joining the team on a full time basis. The new joiners are: • Asma Shirazi - Account Director • Emily Sidlow - Senior Account Manager • Isabelle Nicholson-Rose - Account Executive They will all be joining the Client Services team, headed by Rachel Harris and will be working on clients including Novartis, Abbott Diagnostics, Fresenius Kabi, L&R, Align Technology and IQVIA.
    Full story
  • FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution

    Nov 19, 2020, 14:53 PM by
    Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images
    Full story
  • AVIA Names John Fiacco as Chief Growth Officer

    Nov 19, 2020, 14:52 PM by
    Full story
  • Dotmatics collaborates with LabVoice to enable voice-assisted laboratory workflows

    Nov 19, 2020, 14:51 PM by
    Full story
  • Behind the VC Curtain: Investors Talk About Post-COVID Trends and the ‘New’ Healthcare Tech

    Nov 19, 2020, 01:00 AM by User Not Found
    Bio-IT World | COVID-19 is switching the risk paradigm for biotech and pharma. It’s too risky, now, not to do something digital. It’s driving changes in investing as well. A recent panel discussion explored how venture capital and new tech companies evaluate technology, invest cash, and plan to move forward.
    Full story
  • Molecular Tagging System With Real-World Potential

    Nov 17, 2020, 01:00 AM by User Not Found
    Bio-IT World | A decades-old technology initially used to hide secret messages in dots of DNA—along with Oxford Nanopore sequencing—could get a reboot as a tracking system for commodities that might be too small or numerous for tagging with QR codes or radio-frequency identification, such as experimental drugs and controlled substances.
    Full story
  • Illumina Announces P3 High-Output Flow Cell, NextSeq 1000

    Nov 13, 2020, 14:26 PM by User Not Found
    Bio-IT World | Illumina has announced the commercial availability of the P3 high-output flow cell, offering 1.1 billion reads in a single sequencing run. The company also announced the commercial availability of the NextSeq 1000.
    Full story
  • New Rhesus Macaque Model, Six SARS-CoV-2 Strains, the Structure of Dexamethasone with Serum Albumin: COVID-19 Updates

    Nov 13, 2020, 01:00 AM by User Not Found
    Bio-IT World | A look at how COVID-19 patients fare after recovery, Mount Sinai’s new ML model analyzes EHRs, overlapping genes in viruses, conferred immunity from other coronaviruses, and a picture of RNA-RNA interactions. Plus a new Intel system at LLNL for COVID-19 research, Baylor’s coronavirus curriculum, and a recommended vaccine distribution framework.
    Full story
  • Big Data, Supercomputing Deployed For Disease Risk Prediction Models

    Nov 12, 2020, 01:00 AM by User Not Found
    Bio-IT World | The Department of Veterans Affairs (VA) and the Department of Energy (DOE) have teamed up to develop disease risk prediction models using deep learning, according to Ravi Madduri, a computer scientist at the DOE’s Argonne National Laboratory and co-lead of the collaboration.
    Full story
  • Fall New Products, News From DNAnexus, Immunai, Thermo Fisher, More

    Nov 11, 2020, 14:51 PM by User Not Found
    Bio-IT World | New products, collaborations and deployments from the past two months from Quantum, Mission Bio, Seqster, Takeda, Optibrium, the Pistoia Alliance, Caris Life Sciences, Genomenon, and more.
    Full story
  • Bryn Roberts: Reflections on Pharma’s Scientific Computing Journey

    Nov 10, 2020, 01:00 AM by User Not Found
    Bio-IT World | Pharma has had a long history with data. Of course, it wasn’t always digital but there’s always been a data trail. We asked Bryn Roberts from Roche for insights gleaned from his nearly three decades in the pharma industry, mainly in roles related to data science, information technology, and automation. Generating and collecting data has never really been a problem, he said. Managing it, however, has always been a challenge.
    Full story
  • Synthetic Nanobody Potential Treatment, Red Marrow Main Target, Europe Source Of Spread: COVID-19 Updates

    Nov 6, 2020, 10:38 AM by User Not Found
    Bio-IT World I Isolated cannabis compounds decrease cytokines, spike protein disrupts blood-brain barrier, aprotinin potential treatment, D614F mutation made virus more contagious, seven forms of disease identified, and new nanoparticle vaccine a promising candidate. Plus: Cornea of the eye may be resistant, propranolol reduces inflammation, autoimmune antibody culprit for blood clots, and lung damage found in ‘long COVID’.
    Full story
  • Setting Your Group Up For Data Governance Success

    Nov 5, 2020, 14:58 PM by User Not Found
    Bio-IT World | Data governance is a somewhat fluid term, encompassing all aspects of making sure our data are accurate, consistent, current, and secure. Successful data governance relies on input from scientists, IT teams, and executives, and it must remain flexible as stakeholders change, business interests evolve, and collaborations mature.
    Full story
  • Real Progress In Crowdsourcing Scientific Tasks To Gamers

    Nov 4, 2020, 12:56 PM by User Not Found
    Bio-IT World | Gaming and science—two seemingly incompatible areas of activity—have come together nicely in the case of citizen science games such as Foldit, Phylo, and Borderlands Science, as reported by academics close to the action who presented at the recent Bio-IT World Conference & Expo Virtual. The games are all played online, involve analyzing large sets of data, and endeavoring to solve real scientific problems. And players get credit individually (when willing) or as a crowd when findings appear in scholarly, peer-reviewed publications.
    Full story
  • Mini-Lungs In A Dish, Airway Stem Cells, Evolution of Virus Mutations: COVID-19 Updates

    Oct 30, 2020, 10:51 AM by User Not Found
    Bio-IT World I Neutrons chart atomic map of COVID-19’s viral replication, Organs-on-Chips technology, coronaviruses mimic proteins that control blood coagulation and inflammation, therapeutic effects of Chinese herbal medicine, crystal structure identified on SARS-CoV-2 papain-like protease, and potent antibody isolated. Plus: NIH researchers discover key pathway in lysosomes for coronaviruses exit, deep learning models to target SARS-CoV-2 main protease, RBD nanoparticles may be effective vaccine, predicting outbreaks, virus may ‘hide’ in asymptomatic people, and NYC outbreak linked to Europe.
    Full story
  • Dyadic C1 protein expression platform explored in fight against COVID-19

    Oct 30, 2020, 09:51 AM by Abhinav Singh
    JUPITER, FL, UNITED STATES - Oct 30, 2020 - Dyadic International, Inc. (NASDAQ: DYAI) a leading biotechnology innovator focused on accelerating the development and lowering the manufacturing costs of vaccines and biopharmaceuticals, recently announced results which further support record expression levels of the SARS-CoV-2 Receptor Binding Domain (RBD) antigen produced from Dyadic’s industrially proven proprietary & patented hyper-productive C1 gene expression platform
    Full story
  • Muscular Dystrophy Association Launches MOVR Visualization and Reporting Platform to Improve Patient Care and Accelerate Drug Discovery

    Oct 29, 2020, 14:22 PM by Abhinav Singh
    NEW YORK, NY, UNITED STATES - Oct 29, 2020 - The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP)
    Full story
  • Plus Therapeutics Announces Initiation of Final Cohort of ReSPECT™ Glioblastoma Trial

    Oct 29, 2020, 08:27 AM by Abhinav Singh
    AUSTIN, TX - Oct 29, 2020 - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has treated the first patient in the sixth and final cohort of its National Cancer Institute (NCI)-supported, multi-center ReSPECT™ Phase 1 dose-finding clinical trial evaluating Rhenium NanoLiposomes (RNL™) for the treatment of recurrent glioblastoma (GBM)
    Full story
  • 7th Crystal Structure Prediction Blind Test brings new challenges for computational chemists

    Oct 28, 2020, 07:02 AM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 28, 2020 - Announcing the new challengeThis week the 7th CSP Blind Test begins - a major challenge in computational chemistry
    Full story
  • Follow the Money: Microbiome, ‘Omics, Vaccine Patches

    Oct 28, 2020, 04:00 AM by Michael Croft
    Bio-IT World | Money for oral microbiome drugs, ‘omics, a biology plus technology transistor, digital biomarker platform, a vaccine patch that doesn’t require refrigeration, and more.
    Full story